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The transmission of milk-borne or exogenous mouse mammary tumor virus (MMTV) requires infection of B cells in the gut-
associated lymphoid tissue and expression of the superantigen (Sag) protein at the B-cell surface. Presentation of Sag at the
B-cell surface is required for the transmission of MMTV to T cells and subsequent infection of the target mammary gland
tissue. Because several different promoters have been reported for MMTV sag mRNA expression, we investigated whether
the detection of spliced sag RNAs was dependent upon the cell type infected or the particular MMTV strain examined. In this
study, we detected expression of spliced sag RNA from the standard promoter and from an internal U3 promoter in B-cell lines
expressing endogenous Mtv-6 by RT-PCR, although expression from the standard promoter appeared to be at least 10-fold
higher than that observed from the internal U3 promoter. Sag RNA originating from exogenous C3H MMTV was not observed
from either of the U3 promoters in any cell type examined. However, spliced mRNAs containing the exogenous C3H MMTV,
endogenous Mtv-8, or endogenous Mtv-17 sag genes could be detected from a previously described promoter in the envelope
coding region regardless of the cell type infected. Because sag-specific RNAs can be initiated independently of the LTR
promoters, there may be selection for independent control of MMTV sag and structural gene expression. q 1997 Academic Press
INTRODUCTION largely as a result of low-level sag gene expression and
difficulties in the production of specific Sag antibodies
Mouse mammary tumor virus (MMTV) is transmitted (Mohan et al., 1993; Xu et al., 1996). Expression of the
from mothers to offspring through infected milk (Hilgers MMTV sag gene has been reported from at least three
and Bentvelzen, 1978). During the first few weeks of life, different promoters, resulting in transcripts that initiate
the ingested virus passes through the stomach to the at the U3/R border from the standard promoter in the long
intestine where B and T cells are encountered in the gut- terminal repeat (LTR) (van Ooyen et al., 1983; Wheeler et
associated lymphoid tissues (Karapetian et al., 1994; Xu al., 1983), from a position approximately 500 bp upstream
et al., 1996). Infection of B cells leads to the expression of the U3 promoter (Gunzburg et al., 1993), or from a
of the superantigen or Sag protein at the cell surface position within the envelope region (Elliott et al., 1988;
in conjunction with the major histocompatibility complex Miller et al., 1992). Because of difficulties associated with
(MHC) class II protein (Acha-Orbea et al., 1991; Karapetian in vitro assays for Sag function and the time-consuming
et al., 1994). The Sag–MHC class II complex on B cells is and cumbersome nature of in vivo tests for Sag function,
recognized by certain classes of T cells that have specific it has been difficult to determine whether one or more
variable regions on the b chain of the T-cell receptor of the described RNAs is used for expression of the sag
(TCR) (Janeway, 1991). Engagement of the TCR by the Sag gene from different MMTV proviruses.
complex results in T-cell stimulation and the release of In this study, we have examined whether differences
cytokines which allow MMTV infection of additional B and in spliced sag RNA expression were cell type-specific or
T cells (Golovkina et al., 1992; Held et al., 1994). These whether the promoter used for spliced sag RNA expres-
infected lymphocytes presumably act as a reservoir for the sion was dependent upon the MMTV strain examined.
transmission of MMTV to the target tissue in the mammary Our data indicated that spliced sag RNA expression was
gland (Held et al., 1994). Multiple cycles of mammary cell dependent on the MMTV strain examined and that the
replication during pregnancy and lactation allow efficient milk-borne C3H MMTV does not use the LTR promoters
MMTV integration and production of large amounts of for sag expression.
virus particles into milk (Peters and Dickson, 1987).
The expression of the superantigen or sag gene and
MATERIALS AND METHODSits products during the virus life cycle remains an enigma,
Mice
1 To whom correspondence and reprint requests should be ad-
BALB/c, C58/J, and PERA/Ei mice were purchaseddressed at Department of Microbiology, ESB 226, University of Texas
from The Jackson Laboratories (Bar Harbor, ME) andat Austin, Austin, TX 78712-1095. Fax: (512) 471-7088. E-mail: jdudley@
uts.cc.utexas.edu. C3H/HeN Mtv/ were purchased from Harlan Sprague–
540042-6822/97 $25.00
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FIG. 1. Proposed structure for spliced MMTV RNAs from promoters in the U3 and envelope regions. Location of primers for RT-PCR are designated
as letters, and the arrows indicate the direction of priming. The V-shaped regions are spliced out in the mature RNAs. All RNAs are shown with
respect to a provirus containing the viral structural genes, gag, pol, and env. LTRs are shown as boxes.
Dawley (Houston, TX). Mtv-17-only mice were identified cells were cultured in Dulbecco’s modified Eagle’s me-
dium with sodium pyruvate (DMEM) (GIBCO BRL, Grandby Southern blotting of tail DNA from (C58/J1 PERA/Ei)1
PERA/Ei backcross mice. Newborn animals were either Island, NY) containing 10% (v/v) fetal bovine serum (FBS)
(HyClone Laboratories, Inc., Logan, UT) and antibiotics.nursed on their natural mothers or foster-nursed on C3H/
HeN Mtv/ mothers within 3 days of birth. Mice were LBB.A and A20 cells were grown in RPMI 1640 medium
containing 10% FBS, 5 1 1005 M 2-mercaptoethanol, andbred and housed at the Animal Resources Center at the
University of Texas at Austin. 10 mM HEPES (N-2-hydroxyethylpiperazine-N*-2-ethane-
sulfonic acid), pH 7.4. XC and LBB.A cells were trans-
Cell culture fected with an infectious MMTV provirus, HYB MTV
(Shackleford and Varmus, 1988), by electroporation asMm5MT (a C3H mammary tumor cell line) (Owens and
described previously (Xu et al., 1996) in the presence ofHackett, 1972) and A20 (a BALB/c B-cell lymphoma that
the selectable marker pSV2neo (Southern and Berg,is MHC class II-positive) (Kim et al., 1979) were obtained
from the American Type Culture Collection (Rockville,
MD). A B-cell hybridoma (BALB/c 1 RF/J), LBB.A (Nicolas
et al., 1987) kindly was provided by Dr. Brigitte Huber
(Tufts University). XC cells (Klement et al., 1969) were
obtained from Dr. Rex Risser (University of Wisconsin,
Madison). The 40-40 hybridoma cells (Mudgett-Hunter et
al., 1985) were derived from a fusion between a BALB/c
myeloma and A/J spleen cells. Mm5MT, XC, and 40-40
FIG. 3. Detection of RT-PCR products derived from the internal U3
promoter. RT-PCRs were performed using primers B and E (lanes 2
and 3), primers B and G (lanes 4, 5, and 10), primers C and E (lanes
6 and 7), primers C and G (lanes 8 and 9), and primer B and C3H-
specific primer H (lane 11). Reactions in lanes 3, 5, 7, and 9 show the
results using total RNA from A20 cells, whereas reactions in lanes 10FIG. 2. Expression of spliced sag RNA in B-cell lines. RNA from A20
(B-cell lymphoma) and LBB.A (B-cell hybridoma) lines was isolated after and 11 used total spleen RNA from a HYB MTV-transgenic mouse.
Lanes 1 and 12 show a digest of pUC19 DNA, and lanes 2, 4, 6, andgrowth in the presence (/) (lanes 4 and 6) or absence (0) (lanes 3
and 5) of dexamethasone and subjected to RT-PCR using primers A 8 show RT-PCRs without added template. The detected sag products
are a few hundred bases shorter than the predicted sag RNA from theand G. Lanes 1 and 2 contained a digest of pUC19 DNA and an RT-
PCR without added template, respectively. internal U3 promoter (Gunzburg et al., 1993).
AID VY 8717 / 6a41$$$241 08-14-97 18:39:31 vira AP: VY
56 XU, WRONA, AND DUDLEY
FIG. 4. Structure and sequence of doubly spliced RNAs derived from the internal U3 promoter. (A) Structure of the proposed and detected RNAs
initiated from the internal U3 promoter relative to the MMTV provirus. The splice donor (sd) and acceptor (sa) sites are indicated on the RNAs. The
V-shaped regions are spliced out. Small arrows with letters designate the location of primers used. (B) The sequences of two types of cloned RT-
PCR products obtained using primers B and E or primers B and G and RNA from A20 cells are shown. The sequence begins at LTR sequence 778
according to Brandt-Carlson et al. (1993) with a discontinuity at LTR position 29 just downstream of the presumed sag initiation codon. Primers
used in RT-PCRs are shown by arrows. U5- and sag-coding regions are indicated and splice junctions are shown with vertical lines. Dots show
the identity between sequences and dashes indicate the deleted nucleotides. Only portions of the B/G primer clones were sequenced. Nucleotide
positions are shown relative to the first base of the LTR. No attempt was made to sequence all of the clones obtained from either the B/E or the
B/G PCRs, and therefore, the relative frequencies of these spliced products could not be assessed. (C) The sequence of the novel splice junctions
have been compared to consensus splice donor and acceptor sites (Horowitz and Krainer, 1994). The sequences for the introns were taken from
the RIII virus (Moore et al., 1987), the C3H LTR (Brandt-Carlson et al., 1993), and Mtv-6 (Cho et al., 1995). No strain differences were observed.
1982). Transfected cells were selected in growth medium tion of the internal U3 promoter transcript were primer B
(5* CTAGACCTCCTTGGTGTATGTTGTC 3*) and primer Gcontaining 1 mg/ml G418 (GIBCO BRL).
or primer C (5* GGAAAGATTTTCCATACC 3*) and primer
G. Primers B and C also were used in conjunction withRNA extractions and RT-PCR
primer E (5* TCAACCATTTCTGCTGCAGG 3*) or C3H-
The guanidine isothiocyanate method was employed for specific primer H in the LTR polymorphic region (5* TAC-
RNA extractions as described previously (Xu et al., 1996). TTCTAGGCCTGTGGTCA 3*). Primer H has been shown
DNA and low-molecular-weight RNAs were removed by to be specific for C3H MMTV sequences in control reac-
precipitation with sodium acetate (Palmiter, 1974), and the tions (not shown). Primer I (5* ATCGCCTTTAAGAAGGAC-
concentration of high-molecular-weight RNAs was quanti- GCCTTCTTCT 3*) for the envelope promoter was used
tated at 260 nm by spectrophotometry. The integrity of in reactions with either primer G or primer H. PCR condi-
total RNAs was assessed by the appearance of ribosomal tions for primer pairs that detect the standard U3 pro-
RNAs after electrophoresis in denaturing agarose gels moter were 937 for 1.5 min, 577 for 1 min, and 727 for 1
containing 1% formaldehyde (Brown, 1993). min (40 cycles). PCR conditions for primer pairs that de-
RT-PCRs were performed as described by Xu et al. tect the internal U3 promoter were 947 for 1.5 min, 557
(1996), and one-fifth of each reaction was analyzed on for 1.5 min, and 727 for 3 min (5 cycles) followed by 947
agarose gels. In some cases, Supermix (GIBCO BRL) for 1.5 min, 507 for 1.5 min, and 727 for 3 min (35 cycles).
was used. Approximately 1/20 to 1/40 of cDNA samples Conditions for primer pairs that detect the envelope pro-
was used for PCR; however, similar results were ob- moter were 947 for 1.5 min, 557 for 1.5 min, and 727 for
tained if 1/3200 of the cDNA preparations was used for 2 min (5 cycles) followed by 947 for 1.5 min, 507 for 1.5
PCRs with GAPDH primers. The primers used for detec- min, and 727 for 2 min (35 cycles). Each primer set was
tion of U3 promoter transcripts were primer A (5* GTG- optimized for magnesium concentration and cycling con-
AATTCCATCACAAGAGCGGAACGGAC 3*) [5* base at ditions. Primers for GAPDH and conditions for PCR have
position 230 on the sequence of Majors and Varmus been described previously (Xu et al., 1996). Semiquantita-
(1983)] and primer G (5* GAGGTTGAGCGTCTCTTT- tive PCRs were performed using cDNAs synthesized in
CTATT 3*) [5* base at position 2824 on the sequence of reactions containing 37.5 mg/ml random decamers. Se-
rial dilutions of cDNA were used in PCRs containing 50Majors and Varmus (1983)]. Primers used for the detec-
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FIG. 4—Continued
pmol of each primer (either primers A and H or primers 5* RACE reactions
I and H) and Supermix (GIBCO BRL). PCRs were per-
Total RNA (1 mg) from the B-cell hybridoma line 40-formed at 947 for 1.5 min, 557 for 1.5 min, and 727 for 2
40 (Mudgett-Hunter et al., 1985) was used in 5* RACEmin for 5 cycles and then at 947 for 1.5 min, 507 for 1.5
reactions according to the conditions given for themin, and 727 for 2 min for 25 cycles.
GIBCO BRL 5* RACE system. Reverse transcription was
Cloning of PCR products and sequencing analysis primed by 2.5 pmol of primer G. Following RNase diges-
tion, the cDNA was purified on a GLASSMAX spin car-PCR products were purified on spun Sephadex G-50
tridge, and one-fifth of the eluate was tailed in a 25-(Sigma Chemical Co., St. Louis, MO) columns as de-
ml reaction using terminal deoxynucleotidyl transferasescribed by Sambrook et al. (1989) before use in ligation
(TdT). Tailed cDNA (5 to 15 ml) was used in PCRs withreactions using the TA cloning kit (Invitrogen, San Diego,
a 5* anchor primer (5* CUACUACUACUAGGCCACGCG-CA) as suggested by the manufacturer. Individual cloned
TCGACTAGTACGGGIIGGGIIGGGIG 3* and a nested LTRPCR products were sequenced using the Sequenase
3* primer [either primer F (5* GCAAAGCAGAGCTATGCCVersion 2.0 DNA Sequencing Kit (United States Biochemi-
cal Corp., Cleveland, OH). 3*) or primer D (5* CGTTAAGATCTGACTGCACTTGG 3*)].
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ous primer combinations and RNA derived from A20 cells
(Fig. 3). Using a plus-strand primer (primer B) located
approximately 420 bp upstream of the standard promoter
and a minus-strand primer (primer E) located approxi-
mately 10 bp from the start of the U3 region, we observed
a PCR product of about 350 bp (Fig. 3, lane 3). Unexpect-
edly, this product was 400–500 bp shorter than that pre-
dicted by Gunzburg et al. (1993). We also detected a
product of about 850 bp using the same plus-strand
primer (primer B) and a minus-strand primer (primer G)
located 500 bp from the 5* end of the U3 region (Fig. 3,
lane 5). Again, this product was about 500 bp shorter
than predicted from previous data (Gunzburg et al., 1993).
Use of a plus-strand primer (primer C) located approxi-
mately 320 bp upstream of the U3/R junction with minus-
strand primer E or G failed to detect RNA from the pro-
posed U3 promoter (Fig. 3, lanes 7 and 9). Thus, we could
detect expression from the upstream U3 promoter in B
cells with primer B, but not with primer C, and the size
FIG. 5. RACE reactions to determine the 5* end of spliced sag tran- of the spliced RNA detected was smaller than anticipated.
scripts. (A) RACE reactions using the BRL anchor primer and an MMTV
(Primer C was shown to function in control PCRs withLTR primer (primer F) (3* end at /155 relative to the 5* end of the C3H
DNA templates.) Together, these results suggested thatMMTV LTR). Lane 1, reaction using dC-tailed cDNA; lane 2, reaction
using cDNA without tailing by terminal transferase; lane 3, HaeIII-digested the RNAs detected by PCR and primer B were consistent
fX174. (B) RACE reactions using the BRL anchor primer and primer D with use of the internal U3 promoter, but were the result
(3* end approximately 20 bp downstream of the splice acceptor site). of at least two splicing events.
Lane 1, HaeIII-digested fX174 DNA; lane 2, reaction using dC-tailed
To further characterize the RNA structures detected incDNA; lane 3, reaction using cDNA without tailing by terminal transferase.
RT-PCRs with primer B, the products obtained from A20
Samples were subjected to thermal cycling under condi-
tions described for GAPDH cDNA.
RESULTS
Expression of endogenous sag RNA in B cells
Previously we used RT-PCR analysis to detect spliced
sag transcripts initiated from the endogenous Mtv-6 and
Mtv-17 LTR promoters, but not exogenous C3H MMTV
LTRs, in lymphoid tissues of MMTV-infected mice (Xu et
al., 1996). To further characterize these transcripts, we
used RNA derived from several MHC class II-positive B-
cell lines, A20 (containing Mtv-6, 8, and 9) and LBB.A
(containing Mtv-1, 6, 7, 8, 9, and 17) (Beutner et al., 1992),
for RT-PCR using primers A and G, which will detect all
known MMTV strains (see Fig. 1). These primers detect
spliced sag RNAs that initiate at the U3/R junction from
the standard MMTV promoter (van Ooyen et al., 1983;
FIG. 6. Failure to detect spliced sag transcripts from the C3H MMTVWheeler et al., 1983) or approximately 500 bp upstream
U3 promoters. Total RNA was isolated from a C3H/HeN mammaryat an internal U3 promoter (Gunzburg et al., 1993).
tumor (7.5-month-old lactating C3H female), C3H/HeN thymus, or XC
As anticipated, a PCR product of approximately 650 bp cells transfected with an infectious MMTV hybrid provirus containing
was observed in reactions obtained from either A20 or the C3H MMTV sag gene (Shackleford and Varmus, 1988) (XC/HP).
RNA samples were used for RT-PCR using MMTV-specific primers ALBB.A cells (Fig. 2, lanes 3– 6). This product was induced
and G to detect spliced sag transcripts from the U3 promoters (lanes 3–less than fivefold when RT-PCR was performed using
5). Similar results were obtained for all RNAs in RT-PCRs with GAPDHRNA extracted from cells grown in the presence of dexa-
primers, but results only are shown for the C3H tumor (lane 6). Lane
methasone. To determine whether these transcripts origi- 2 shows PCR without added template for primers A and G (NT), whereas
nated from the standard U3 promoter or the internal U3 lane 1 shows a restriction digest of pUC19 DNA used as a molecular
weight marker (M).promoter, we performed RT-PCR experiments using vari-
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RNA with primers B and E or primers B and G were cloned, sulting cDNA products were tailed with dCTP using termi-
nal deoxythymidylate transferase and then used in PCRsand a partial sequence was obtained (Fig. 4B). Compari-
son of sequences from several PCR clones obtained with with an anchor primer containing multiple G and I residues
and a nested antisense LTR primer located 5* to primerprimers B and G with those from the endogenous Mtv-6,
Mtv-8, and Mtv-9 LTRs (endogenous MMTVs found in the G (primer F). As predicted, the product obtained from these
reactions was approximately 600 bp, consistent with initia-BALB/c-derived A20 cell line) revealed a discontinuity at
position 829 from the sequence of Brandt-Carlson et al. tion of most endogenous sag RNA at the U3/R junction
(Fig. 5A, lane 1). A PCR product derived from the novel(1993), where there appeared to be a splicing event to a
sequence within the U5 region. Further sequencing of the U3 promoter was predicted to be 1100 bp. The dC tailing
of the 600-bp product was essential for the reaction sincesame products showed a second splicing event at the
sequence previously shown for sag mRNA (Jarvis et al., this product was not obtained if the TdT step was omitted
from the procedure (Fig. 5A, lane 2). To determine whether1994) (see structure in Fig. 4A). Sequencing of a PCR
clone obtained with primers B and E also revealed a dis- the internal U3 promoter could be detected if a shorter
PCR product was generated, we used a 3* primer locatedcontinuity at position 829, but in this case, the splice ac-
ceptor was located within the leader region. Again, the very close to the 3* splice acceptor site (primer D). In this
case, the anticipated 400-bp product was obtained; again,primer B/E product had the second splice junction pre-
dicted for sag mRNA (Jarvis et al., 1994). Partial sequenc- this product was consistent with sag RNA initiation at the
U3/R border (Fig. 5B, lane 2). Although our failure to detecting of the remainder of both types of clones suggested that
the clones were derived from endogenous Mtv-6 (Brandt- the longer PCR product from the internal U3 promoter
could be explained by the lower efficiency of these reac-Carlson et al., 1993). Therefore, sequencing of the PCR
clones revealed that sag transcripts initiating from the tions, we estimate that generation of the 900-bp product
from internal U3 promoter transcripts would have to beinternal U3 promoter were doubly spliced, and this result
explained our failure to detect such transcripts with primer 10-fold less than that from the standard U3 promoter (as-
suming equal use of these promoters) to avoid detection.C (see Fig. 4A). It should be noted that both products
appeared to be the result of mRNA splicing rather than Alternatively, the RACE experiments, similar to the RT-
PCR assays, are consistent with the low abundance ofPCR artifacts since both the splice donor and the alternate
acceptor sites were highly related to splice donor and transcripts from the internal U3 promoter compared to
transcripts from the standard MMTV promoter in B cells.acceptor consensus sequences (Fig. 4C).
To determine whether transcripts from the internal U3
promoter were detectable in vivo, we extracted RNAs Expression of sag RNA from the env promoter
from the tissues of C3H MMTV-infected BALB/c or C3H/
HeN mice. Using conditions previously described for the Our previous data showed that sag-specific transcripts
originating from one or both of the U3 promoters coulddetection of the sag RNA with primers A and G (Xu et
al., 1996) (Fig. 1), no transcripts could be observed using be detected in the lymphoid tissues of C3H MMTV-in-
fected mice (Xu et al., 1996). Surprisingly, restriction en-primers B and E or primers B and G. However, use of
approximately 10-fold more PCR products for gel analysis zyme digestions, cloning, and sequencing of the RT-PCR
products indicated that none of these products originateddetected PCR products of the same size as those seen in
A20 cells from the internal U3 promoter (data not shown). from the infecting C3H MMTV (Xu et al., 1996). Because
this result may be due to the low abundance of the C3HAnalysis of spleen RNA from mice carrying an infectious
MMTV proviral transgene (Golovkina et al., 1994) also sag transcripts relative to the endogenous MMTV tran-
scripts or the infection of small numbers of lymphoidallowed the detection of sag transcripts from the internal
U3 promoter using primers B and G (Fig. 3, lane 10). This cells or both, we analyzed rat XC cells that had been
transfected with an infectious MMTV provirus (Shack-product was derived from one of the endogenous MMTVs
of C3H mice (Mtv-1, 6, 8, 11, or 14), probably Mtv-6 (Xu leford and Varmus, 1988) or a C3H MMTV-induced mam-
mary tumor by RT-PCR with primers A and G (Fig. 6). Bothet al., 1996), since this band was not obtained in the
presence of C3H MMTV-specific primers (Fig. 3, lane 11 of these RNA samples had high levels of C3H MMTV
transcripts as measured by strain-specific RNase protec-and data not shown).
Because PCRs with primers A and G could not distin- tion assays (Wrona and Dudley, 1996), and the trans-
fected XC cells were shown to express virus encodingguish between RNAs initiated from the internal U3 pro-
moter (0500) or the standard U3 promoter (/1), we used a C3H MMTV-specific sag gene as demonstrated by in-
jection of BALB/c mice and deletion of Vb14/ T cellsB-cell RNA in 5* RACE (rapid amplification of cDNA ends)
(Frohman et al., 1988) to determine the major site of sag (data not shown). As expected from our previous results
(Xu et al., 1996), thymic RNA from C3H MMTV-infectedRNA initiation (Fig. 5). cDNA was synthesized using primer
G and RNA derived from a B-cell hybridoma expressing mice produced a sag transcript originating from endoge-
nous MMTVs (Fig. 6, lane 4), but the C3H mammaryhigh levels of endogenous MMTV sag RNA as determined
by Northern blotting (Yang and Dudley, 1992). The re- tumor and the transfected rat XC cells did not. [The C3H
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FIG. 7. Detection of spliced sag transcripts from the env promoter of C3H MMTV. (A) RT-PCRs with primers A and H (lanes 2–6) or primers I
and H (lanes 7–11) were performed using no RNA (lanes 6 and 11) or total RNA extracted from LBB.A cells (lanes 2 and 7), LBB.A cells transfected
with an infectious MMTV provirus containing the C3H MMTV sag gene (Shackleford and Varmus, 1988) (lanes 3 and 8), XC rat cells (lanes 4 and
9), or XC cells transfected with the infectious MMTV provirus (lanes 5 and 10). Molecular weight markers are shown in lanes 1 and 12. (B) RT-
PCRs with primers I and H were performed using total RNA extracted from the liver of transgenic mice containing an infectious MMTV hybrid
provirus (lane 3), total RNA from the spleen of the infectious MMTV transgenic mice (lane 4), XC cells transfected with the infectious MMTV provirus
(lane 5), Mm5MT mouse mammary tumor cells producing C3H MMTV (lane 6), and a C3H/HeN Mtv/ mammary tumor (lane 9). The reaction shown
in lane 2 had no added cDNA template, and a molecular weight marker containing a digest of pUC19 DNA is shown in lanes 1, 7, and 8. (C) A
diagram of the 725-bp PCR products obtained with primers I and H is shown relative to the position of the ClaI restriction enzyme site and the
splice donor/acceptor site. (D) ClaI digestion of PCR products generated using primers I and H and RNA extracted from infectious MMTV hybrid
provirus transfected LBB.A cells, infectious MMTV hybrid provirus transgenic mouse spleen, MMTV hybrid provirus transfected XC cells, or Mm5MT
mammary tumor cells. The products of ClaI digestion are indicated by arrows. Digests of pUC19 DNA are given as molecular weight markers in
lane 1. Some of the full-length PCR product (725 bp) remains in each lane, presumably due to inhibition of ClaI cleavage by PCR conditions. Different
amounts were digested in each reaction, and therefore, these results are not quantitative.
mammary tumor did not express endogenous MMTVs as a C3H-specific primer within the polymorphic region of
the sag gene in RT-PCRs (primer H) to detect C3H sagdetected by RNase protection assays (not shown) and
rat cells lack endogenous MMTVs (Ringold et al., 1977)]. transcripts consistent with the use of the env promoter
(Fig. 7A). Because of the 1.2-kb intron in the describedAll of the PCRs contained equivalent levels of cDNA as
judged from reactions with GAPDH primers (lane 6 and env promoter transcript (Elliott et al., 1988), we used PCR
conditions that would not favor detection of gag-pol ordata not shown), and samples used for lanes 3 and 5
were positive using other sets of MMTV primers (see env mRNA (see Fig. 1). As anticipated, uninfected B-cell
lines that express endogenous MMTVs, LBB.A (Fig. 7A,below). We also tested the B-cell line LBB.A or rat XC
cells transfected with an infectious MMTV provirus car- lane 7), and XC rat cells (lane 9) contained no C3H-
specific sag transcripts. However, RT-PCR products ofrying the C3H MMTV sag gene (Shackleford and Varmus,
1988) by RT-PCRs with primers A and H. Use of a primer 725 bp were detectable in LBB.A cells transfected with
an infectious MMTV hybrid provirus (Fig. 7A, lane 8), inspecific for the C3H LTR (primer H) did not detect tran-
scription of the C3H sag gene from the U3 promoters XC cells transfected with the infectious hybrid provirus
(Fig. 7A, lane 10 and Fig. 7B, lane 5), in spleen cells(Fig. 7A, lanes 2–5). Together with our previous cloning
and sequencing data (Xu et al., 1996), these results sug- from C3H mice containing the infectious provirus as a
transgene (Golovkina et al., 1994) (Fig. 7B, lane 4), ingested that neither of the U3 promoters in the LTR was
used for expression of a spliced sag-specific RNA. Mm5MT C3H mammary tumor cells (Fig. 7B, lane 6), and
in an MMTV-induced C3H mammary tumor (Fig. 7B, laneA third promoter for the sag gene that is active for
the expression of reporter genes has been described 9). C3H-specific sag transcripts were not detectable from
the livers of C3H mice containing an infectious MMTVpreviously (Elliott et al., 1988; Miller et al., 1992). This
promoter is located within the envelope gene and con- transgene (Fig. 7B, lane 3), a result expected because of
the lack of MMTV transcription in liver (Henrard andtains a novel splice donor site that is used in conjunction
with the splice acceptor site just upstream of the 3* LTR Ross, 1988; Ross et al., 1990).
To confirm that the RT-PCRs from primers I and H de-(van Ooyen et al., 1983; Wheeler et al., 1983). We used
a primer upstream of the env splice donor (primer I) and tected C3H-specific sag transcripts, a portion of the prod-
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a C3H MMTV-specific primer (not shown). To confirm
this, RT-PCR products derived from primers I and G using
A20 RNA were cloned and sequenced (Fig. 8B). These
products had the previously described splice donor/
splice acceptor junction (Elliott et al., 1988) and, with the
exception of a single nucleotide just upstream of the
splice donor site, had a sequence identical to that pre-
dicted for the endogenous Mtv-8 provirus (Kennedy et
al., 1982). Data by Jarvis et al. (1994) indicated that
spliced sag transcripts are detectable from the Mtv-8 LTR
promoters. As expected, we did not detect transcripts
from Mtv-6, a deleted provirus known to lack most of the
gag, pol, and env genes (Cho et al., 1995).
We performed RT-PCR experiments to determine spe-
cifically whether Mtv-17 expressed spliced sag tran-
scripts consistent with the use of the env promoter (Fig.
8C). Using RNA extracted from the salivary gland of a
mouse carrying only Mtv-17, we observed spliced tran-
scripts of the expected size from the env promoter (lane
3). Mtv-17 transcripts also were detected from the U3
promoters (lane 2) as previously described for gut-asso-
ciated lymphoid tissues of C57BL/6 mice (Xu et al., 1996).
Together with experiments using C3H MMTV-infected
cells, these data indicated that at least three distinct
MMTVs, Mtv-8, Mtv-17, and C3H, expressed sag-specific
RNAs from the env promoter.
DISCUSSION
Previously at least three different promoters have been
described for the production of spliced sag-specific tran-
scripts: the standard promoter just upstream of the U3/FIG. 7—Continued
R junction (van Ooyen et al., 1983; Wheeler et al., 1983), a
promoter within the sag gene itself (internal U3 promoter)
(Gunzburg et al., 1993), and a promoter within the enve-ucts from transfected LBB.A cells, MMTV hybrid provirus
transgenic spleen, transfected XC cells, and Mm5MT cells lope region (Elliott et al., 1988; Miller et al., 1992). Each of
these promoters is functional in transfection experimentswere digested with the restriction enzyme ClaI (Fig. 7C).
ClaI should cleave PCR products from the exogenous C3H (Morley et al., 1987; Miller et al., 1992; Gunzburg et al.,
1993). However, earlier experiments have not shownLTR, but not products from endogenous MMTVs (Brandt-
Carlson et al., 1993). As predicted, most of the 725-bp RT- whether one or more transcripts from these promoters
are produced by the same strain of MMTV and, in thePCR products were cleaved into fragments of the appro-
priate sizes (491 and 234 bp) (Fig. 7D, lanes 2–5), confirm- case of the envelope promoter, whether spliced sag-con-
taining transcripts are produced in B cells, a cell typeing that the majority of the products originated from C3H
MMTV RNA containing the sag gene. believed to be necessary for Sag presentation to T cells
and transmission of MMTV to the mammary gland (Beut-To determine whether transcripts from the env pro-
moter were detectable only from exogenous C3H MMTV ner et al., 1994; Karapetian et al., 1994). In this paper,
we have shown that transcripts consistent with the useor from other MMTV strains, we used RT-PCR with the
env promoter primer (I) and a primer within the LTR (G) of all three promoters can be detected in B-cell lines, but
the production of these transcripts is dependent uponthat should detect all known MMTV strains (Brandt-Carl-
son et al., 1993). Such assays showed that spliced tran- the MMTV strain examined.
The deleted Mtv-6 provirus clearly expresses func-scripts consistent with the use of the env promoter were
detected in two B-cell lines, A20 and LBB.A, that are not tional Sag protein from one or both U3 promoters (van
Ooyen et al., 1983; Wheeler et al., 1983; Gunzburg etinfected by C3H MMTV (Fig. 8A, lanes 3, 4, 9, and 10). The
PCR products appear to be derived from endogenous al., 1993). Surprisingly, transcripts from the internal U3
promoter gave doubly spliced mRNAs containing the sagMMTVs since the same A20 RNA sample previously was
shown to be negative with the env promoter primer and gene from cells expressing Mtv-6 (Fig. 4A). Such tran-
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FIG. 8. Detection of spliced sag-specific transcripts from the env promoter of endogenous MMTV proviruses. (A) Total RNA was isolated from
A20 or LBB.A B cells and used in RT-PCRs with primers I and G. Each of the cell lines was grown in the presence or absence of 1006 M
dexamethasone (Dex) prior to RNA extraction. Lanes 1 and 7 contain molecular weight markers. (B) RT-PCRs using primers I and G and A20 RNA
were cloned and sequenced. The cloned sequences were compared to the published sequence of Mtv-8 (Salmons et al., 1986). Dots show identity
and dashes indicate differences. (C) RT-PCRs were performed with salivary gland RNA of a male (C58/J 1 Pera) 1 Pera backcross mouse containing
only Mtv-17 (lanes 2 and 3). Salivary gland RNA was used because it showed the highest MMTV expression of the tissues that we tested in this
animal (data not shown). PCRs were performed with primers A and G (lanes 2 and 4) or primers I and G (lanes 3 and 5). Lanes 4 and 5 show
reactions that contained no cDNA template (NT). Lane 1 shows molecular weight markers.
scripts were not reported by Gunzburg et al. (1993); how- tained a previously undetected splice donor site in the
U3 region and an acceptor site in either the U5 regionever, the cell lines that they examined did not contain
Mtv-6. Both of the doubly spliced RNAs from Mtv-6 con- or the gag leader region (Fig. 4B). Because the context
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of the AUGs near the beginning of these doubly spliced cells, indicating that the expression of spliced sag RNA
from the env promoter is not cell type-specific.RNAs is unfavorable for translation (Kozak, 1986) and
because of the low abundance of such RNAs, the func- Intriguingly, of the four types of proviruses from which
tional relevance of such transcripts is unclear. we have detected sag-specific transcripts, Mtv-6 uses
only the U3 promoters, Mtv-8 and 17 use both U3 andAlthough the Mtv-6, Mtv-8, and Mtv-17 sag genes ap-
pear to be expressed from the U3 promoters (Figs. 2, 3, env promoters, and C3H MMTV appears only to use the
env promoter (this paper) (Jarvis et al., 1994). Moreover,and 8C) (Jarvis et al., 1994; Xu et al., 1996), we could not
detect sag transcripts from the U3 promoters of exoge- the Mtv-29 provirus appears to use only the env promoter
to make sag transcripts (Zhang et al., 1996). In the casenous C3H MMTV proviruses by gel electrophoresis of
RT-PCR products (Fig. 6) or by gel electrophoresis fol- of the deleted provirus Mtv-6 which lacks the majority of
the env region (Cho et al., 1995), the reason for our failurelowed by Southern blotting (data not shown). However,
using the same RNA samples, we easily detected tran- to detect sag-specific transcripts from the env promoter
is obvious. However, the other four proviruses appear toscripts from the previously described promoter in the
envelope region of C3H MMTV. Semiquantitative RT-PCR be complete.
experiments indicated that cDNA preparations must be As pointed out by Reuss and Coffin (1995), another
diluted about 1000-fold before spliced C3H sag tran- group of retroviruses, the spumaviruses, use dual pro-
scripts from the envelope promoter were undetectable, moters in the 5* LTR and the env regions for the expres-
whereas spliced C3H sag transcripts from the U3 promot- sion of the bel-1/taf open reading frames (Lochelt et al.,
ers were undetectable using the same cDNA at any dilu- 1993; Campbell et al., 1994). However, at least for C3H
tion (data not shown). MMTV and Mtv-29, the 5* LTR promoters appear not to
be used for sag expression. Why is there differentialSome experiments have suggested that the MMTV env
promoter is active in a cell type-specific manner. For promoter usage for sag RNA expression in various
MMTV strains? At least three (not mutually exclusive)example, the envelope promoter cloned from an unidenti-
fied endogenous MMTV has been shown to direct re- explanations exist. First, sag-specific transcripts from the
U3 or envelope regions may predominate if only oneporter gene expression in various helper T-cell lines in
an orientation-specific manner; however, this promoter promoter or one splice donor site in some proviruses is
functional. For example, Mtv-6 lacks the env promoterwas only weakly active in B-cell lines or other cell lines
(Miller et al., 1992). The 5* end of spliced sag transcripts region (Cho et al., 1995). However, in the case of the
Mtv-29 and C3H MMTV proviruses, both the standard U3was mapped just downstream of an orientation-indepen-
dent enhancer within the envelope region by primer ex- promoter (Zhang et al., 1996) (not shown) and the env
promoter are active (Zhang et al., 1996) (Fig. 7). The splicetension assays (Miller et al., 1992), and cloning and se-
quencing of the transcript revealed a 1.2-kb intron ap- donor site in the leader region of C3H MMTV is active
in the formation of spliced env RNA and the same spliceproximately 90 bp 3* to the transcriptional initiation site
(Elliott et al., 1988). However, in these experiments, the acceptor site is used for sag-specific transcripts from
both U3 and env promoters (van Ooyen et al., 1983;transcript from the env promoter was detected only in
EL4 lymphoma cells by Northern blotting (Elliott et al., Wheeler et al., 1983; Elliott et al., 1988; Miller et al., 1992).
Second, the C3H U3 promoter/enhancer elements may1988). More recently, Zhang et al. (1996) have shown
that the env promoter of Mtv-29 is active in SJL B-cell not be optimal for sag RNA expression in particular cell
types, e.g., antigen-presenting cells, whereas the Mtv-lymphomas also known as reticulum cell sarcomas; the
1.8-kb sag-containing transcript had an initiation site and 6, -8, and -17 proviruses have transcriptional elements
in the U3 region that allow sag RNA expression in thesea splice junction identical to those observed in EL4 cells.
We have extended these studies to show that a transcript cells. Third, the env promoter may have evolved in some
MMTV strains (e.g., C3H) to allow for independent controlconsistent with the use of the env promoter can be de-
tected in primary C3H mammary tumors, a mammary of viral structural gene expression and sag gene expres-
sion. The corollary of this hypothesis is that efficienttumor cell line producing C3H MMTV; XC rat cells or B
cells (LBB.A) transfected with a cloned infectious MMTV; transmission of some MMTV strains, including the C3H
exogenous virus, requires the suppression of viral struc-and spleen, but not liver, of a mouse carrying an infec-
tious MMTV transgene (Fig. 7). Although we attempted tural genes in certain cells that express Sag or vice versa.
Suppression of structural gene expression may diminishto map the initiation site of the env promoter by 5* RACE
(data not shown), we were unsuccessful, probably due the immune response against the virus during the early
stages of infection. In agreement with this, we previouslyto the low level of this RNA in infected or transfected
cells. Nevertheless, in contrast to a previous report (Sam- have shown that expression from the standard U3 pro-
moter of C3H MMTV is suppressed in T cells (Ross etbasivarao and Paetkau, 1996), the activity of the env pro-
moter can be detected by RT-PCR in mammary cells, T al., 1990). Thus, these data suggest that sag expression
is dependent upon the presence or absence of specificcells, and B cells of mice and also in heterologous rat
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